Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexey Boyko

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Neurology|August 31, 2016
Pediatric multiple sclerosis: Escalation and emerging treatmentsTanuja Chitnis, Angelo Ghezzi, Barbara Bajer-Kornek, et al.
Neurology and Therapy|June 21, 2023
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?Jürg Kesselring, Alexey Boyko, Alice Laroni, et al.
BMC Microbiology|January 1, 2020
Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversityMadina Kozhieva, Natalia Naumova, Tatiana Alikina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2017
New insights into the burden and costs of multiple sclerosis in Europe: Results for RussiaAlexey Boyko, Gisela Kobelt, Jenny Berg, et al.
International Journal of Molecular Sciences|August 26, 2015
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and SeverityIvan Kiselev, Vitalina Bashinskaya, Olga Kulakova, et al.
Current Neuropharmacology|August 25, 2021
The Role of D<sub>2</sub>-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple SclerosisMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Journal of Neuroimmunology|January 13, 2018
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remissionNatalia Baulina, Olga Kulakova, Ivan Kiselev, et al.
Cells|February 13, 2019
MiRNAs from <i>DLK1-DIO3</i> Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases SignalingNatalia Baulina, German Osmak, Ivan Kiselev, et al.
International Journal of Molecular Sciences|June 26, 2026
Immune-Related Gene Variants as Modifiers of Multiple Sclerosis SeverityOlga Kulakova, Natalia Baulina, Maxim Kozin, et al.
The New England Journal of Medicine|March 16, 2012
Placebo-controlled trial of oral laquinimod for multiple sclerosisGiancarlo Comi, Douglas Jeffery, Ludwig Kappos, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Neurology|August 31, 2016
Pediatric multiple sclerosis: Escalation and emerging treatmentsTanuja Chitnis, Angelo Ghezzi, Barbara Bajer-Kornek, et al.
Neurology and Therapy|June 21, 2023
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?Jürg Kesselring, Alexey Boyko, Alice Laroni, et al.
BMC Microbiology|January 1, 2020
Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversityMadina Kozhieva, Natalia Naumova, Tatiana Alikina, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2017
New insights into the burden and costs of multiple sclerosis in Europe: Results for RussiaAlexey Boyko, Gisela Kobelt, Jenny Berg, et al.
International Journal of Molecular Sciences|August 26, 2015
Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and SeverityIvan Kiselev, Vitalina Bashinskaya, Olga Kulakova, et al.
Current Neuropharmacology|August 25, 2021
The Role of D<sub>2</sub>-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple SclerosisMikhail Melnikov, Anastasiya Sviridova, Vladimir Rogovskii, et al.
Journal of Neuroimmunology|January 13, 2018
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remissionNatalia Baulina, Olga Kulakova, Ivan Kiselev, et al.
Cells|February 13, 2019
MiRNAs from <i>DLK1-DIO3</i> Imprinted Locus at 14q32 are Associated with Multiple Sclerosis: Gender-Specific Expression and Regulation of Receptor Tyrosine Kinases SignalingNatalia Baulina, German Osmak, Ivan Kiselev, et al.
International Journal of Molecular Sciences|June 26, 2026
Immune-Related Gene Variants as Modifiers of Multiple Sclerosis SeverityOlga Kulakova, Natalia Baulina, Maxim Kozin, et al.
The New England Journal of Medicine|March 16, 2012
Placebo-controlled trial of oral laquinimod for multiple sclerosisGiancarlo Comi, Douglas Jeffery, Ludwig Kappos, et al.
Pageof 7